Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound.

Détails

ID Serval
serval:BIB_14120
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound.
Périodique
Carcinogenesis
Auteur⸱e⸱s
Souici A.C., Mirkovitch J., Hausel P., Keefer L.K., Felley-Bosco E.
ISSN
0143-3334
Statut éditorial
Publié
Date de publication
2000
Peer-reviewed
Oui
Volume
21
Numéro
2
Pages
281-287
Langue
anglais
Notes
Souici A.C. a repris son nom Peyter, AC
Résumé
Exposing the human bronchial epithelial cell line BEAS-2B to the nitric oxide (NO) donor sodium 1-(N,N-diethylamino)diazen-1-ium-1, 2-diolate (DEA/NO) at an initial concentration of 0.6 mM while generating superoxide ion at the rate of 1 microM/min with the hypoxanthine/xanthine oxidase (HX/XO) system induced C:G-->T:A transition mutations in codon 248 of the p53 gene. This pattern of mutagenicity was not seen by 'fish-restriction fragment length polymorphism/polymerase chain reaction' (fish-RFLP/PCR) on exposure to DEA/NO alone, however, exposure to HX/XO led to various mutations, suggesting that co-generation of NO and superoxide was responsible for inducing the observed point mutation. DEA/NO potentiated the ability of HX/XO to induce lipid peroxidation as well as DNA single- and double-strand breaks under these conditions, while 0.6 mM DEA/NO in the absence of HX/XO had no significant effect on these parameters. The results show that a point mutation seen at high frequency in certain common human tumors can be induced by simultaneous exposure to reactive oxygen species and a NO source.
Mots-clé
Antigens, Polyomavirus Transforming/physiology, Bronchi/cytology, Cell Line, Transformed, Codon/chemistry, Codon/genetics, DNA Damage, DNA Fragmentation, Drug Synergism, Epithelial Cells/chemistry, Epithelial Cells/cytology, Genes, p53/drug effects, Genes, p53/genetics, Humans, Hydrazines/pharmacology, Hydrazines/toxicity, Hypoxanthine/metabolism, Lipid Peroxidation, Nitric Oxide/metabolism, Nitric Oxide Donors/pharmacology, Nitric Oxide Donors/toxicity, Nitrogen Oxides, Point Mutation, Reactive Oxygen Species, Superoxides/metabolism, Xanthine Oxidase/metabolism
Pubmed
Web of science
Open Access
Oui
Création de la notice
19/11/2007 13:06
Dernière modification de la notice
20/08/2019 13:42
Données d'usage